A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss.
Okada M, Ogawa H, Takagi T, Nishihara E, Yoshida T, Hyodo J, Shinomori Y, Honda N, Fujiwara T, Teraoka M, Yamada H, Hirano SI, Hato N · Frontiers in neuroscience · 2022
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss.” is organized in H2HUBB under the research focus hydrogen inhalation research study 2022 okada. The publication is cited as Okada M, Ogawa H, Takagi T, Nishihara E, Yoshida T, Hyodo J, Shinomori Y, Honda N, Fujiwara T, Teraoka M, Yamada H, Hirano SI, Hato N, Frontiers in neuroscience, 2022. This study protocol examined A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss. The abstract describes Planned or registered research population; hydrogen delivered as hydrogen inhalation. The abstract reports: This is the first study to investigate the efficacy of H for the treatment of ISSNHL in humans. The results suggest that H therapy…. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen inhalation research study 2022 okada overview
Hydrogen (H) has been reported to be effective in reducing hearing loss due to several causes in animal studies. However, no study has examined… A protocol describes planned methods and does not provide completed outcome evidence.
Study design and hydrogen intervention
Publication type: Study protocol. Evidence type: Protocol or ongoing research. Research model or population: Planned or registered research population. Randomized: Yes. Blinding: Double-blind. Control status: Control group reported.
Delivery method: Hydrogen inhalation.
Reported findings and scientific interpretation
For this hydrogen inhalation research study 2022 okada, the study record reports the following: The abstract reports: This is the first study to investigate the efficacy of H for the treatment of ISSNHL in humans. The results suggest that H therapy…
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.